Alan S. Nies's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 9,302 Common Stock done . Disclosure was reported to the exchange on May 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 41,046 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2023 | 9,302 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 12,658 | 12,658 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 8,032 | 8,032 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 14,402 | 14,402 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2022 | 9,302 | 9,302 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 31,744 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 4,024 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 6,475 | 6,475 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,024 | 4,024 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 27,720 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharmaceuticals Inc | Alan S. Nies | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2021 | 10,638 | 0 | - | - | Restricted Stock Units |